GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: Update on continued expansion of IDTF platform in USA, page-85

  1. 1,708 Posts.
    lightbulb Created with Sketch. 614
    One would like to think dilution via CR won’t be an issue a we approach cashflow neutrality / positivity through the monitoring growth. Dilution through performance issues is probably a real risk/ yes. The catalyst for any SP appreciation upon releasing 4c will be solely on the commentary - not the numbers - as you say.
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.